However, annual review with your GP is advisable to: Ensure adherence to the injection schedule Monitor for any new or worsening symptoms Consider testing for other autoimmune conditions if symptoms develop (particularly thyroid function, as thyroid disease is commonly associated with pernicious anaemia) [2] Gastric cancer risk: Pernicious anaemia is associated with a slightly increased risk of gastric cancer
This analysis looked at data from four major clinical trialscalled Semaglutide Treatment Effect in People with obesity (STEP)involving more than 3,500 participants, funded by the pharmaceutical company that developed semaglutide, Novo Nordisk
Use Case Example: A patient presents with high fasting glucose, but no definitive diagnosis is established
Users are not criticized for eating too much or too little
Key symptoms that may indicate gastritis include: Persistent upper abdominal pain or burning that does not resolve with standard antacids Nausea and vomiting , particularly if vomiting contains blood or resembles coffee grounds Loss of appetite beyond the expected appetite suppression from Wegovy Bloating and early satiety (feeling full quickly after eating small amounts) Indigestion (dyspepsia) that is new, persistent, or worsening It is important to note that whilst Wegovy commonly causes nausea and reduced appetite as part of its therapeutic effect, severe or persistent symptoms warrant further investigation
I am not diabetic since my A1C is 5.5